Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|October 3, 2024
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: Long-Term Clinical OutcomesVivian S Tan, Rohann J M Correa, Timothy K Nguyen, et al.Cureus|January 17, 2020
A Phase II Multi-institutional Clinical Trial Assessing Fractionated Simultaneous In-Field Boost Radiotherapy for Brain OligometastasesGeorge Rodrigues, Slav Yartsev, David Roberge, et al.BMC Cancer|July 8, 2022
Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trialEdward Yu, Alison L Allan, Michael Sanatani, et al.International Journal of Radiation Oncology, Biology, Physics|May 13, 2022
Functional Lung Avoidance for Individualized Radiation Therapy: Results of a Double-Masked, Randomized Controlled TrialBrian P Yaremko, Dante P I Capaldi, Khadija Sheikh, et al.Lancet (London, England)|April 16, 2019
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trialDavid A Palma, Robert Olson, Stephen Harrow, et al.International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term OutcomesStephen Harrow, David A Palma, Robert Olson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2020
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized TrialDavid A Palma, Robert Olson, Stephen Harrow, et al.Cancer|May 24, 2023
Stereotactic ablative radiotherapy before resection to avoid delay for early-stage lung cancer or oligometastases during the COVID-19 pandemic: Pathologic outcomes from the SABR-BRIDGE protocolBiniam Kidane, Ian J Gerard, Jonathan Spicer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2020
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 StudyAnamaria R Yeung, Stephanie L Pugh, Ann H Klopp, et al.Gynecologic Oncology|May 21, 2019
Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapyKaren M Gil, Stephanie L Pugh, Ann H Klopp, et al.Pageof 4